Cytokine levels (IL-6 and INF-γ), acute phase response and nutritional status as prognostic factors in lung cancer

被引:184
作者
Martín, F [1 ]
Santolaria, F [1 ]
Batista, N [1 ]
Milena, A [1 ]
Gonzalez-Reimers, E [1 ]
Brito, MJ [1 ]
Oramas, J [1 ]
机构
[1] Univ La Laguna, Hosp Univ Canarias, Med Interna Serv, Secc Oncol Med, Tenerife, Spain
关键词
IFN-gamma; IL-6; lung cancer; malnutrition; survival;
D O I
10.1006/cyto.1998.0398
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Raised serum levels of interleukin 6 (IL-6) have been described in cancer patients. This cytokine mediates the acute phase response and has been also involved in the pathogenesis of cancer cachexia, The objectives of the present study were: (1) to determine the relationships of IL-6 and other cytokines with neoplasia extension, acute phase response and nutritional status, in lung cancer patients; and (2) to establish the prognostic value of serum cytokine levels. A prospective study in which IL-1, IL-2, IL-6, tumour necrosis factor alpha (TNF-alpha) and inteferon gamma (IFN-gamma) have been determined in 66 newly diagnosed lung cancer patients. Nutritional status was assessed objectively. Serum levels of growth hormone (GH), insulin growth factor 1 (IGF-1) and acute phase reactants as C Reactive Protein, alpha 1 antitrypsin and ferritine, were determined. Increased IL-6 levels were related to extensive disease, impaired performance status, enhanced acute phase response and malnutrition. Raised serum IL-6 levels, extensive disease, low Karnofsky index, malnutrition, acute phase response and low IFN-gamma were all related to a shorter survival. When assessed by a multivariate analysis, IL-6 kept its independent prognostic value together with age, disease extension, and decreased IFN-gamma serum levels. IL-6 is increased in lung cancer patients, enhances the acute phase response in them, and is correlated with poor nutritional status, impaired performance status and shorter survival. (C) 1999 Academic Press.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 37 条
  • [11] GREENBERG AS, 1992, CANCER RES, V52, P4113
  • [12] BLOOD ANALYSES AND SURVIVAL IN SYMPTOM-DETECTED AND SURVEY-DETECTED LUNG-CANCER PATIENTS
    HANNISDAL, E
    ENGAN, T
    [J]. JOURNAL OF INTERNAL MEDICINE, 1991, 229 (04) : 337 - 341
  • [13] HERMOSO FG, 1990, NUTR HOSP, V5, P238
  • [14] ELEVATED ENERGY-EXPENDITURE IN CANCER-PATIENTS WITH SOLID TUMORS
    HYLTANDER, A
    DROTT, C
    KORNER, U
    SANDSTROM, R
    LUNDHOLM, K
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (01) : 9 - 15
  • [15] AUTOCRINE GENERATION AND REQUIREMENT OF BSF-2/IL-6 FOR HUMAN MULTIPLE MYELOMAS
    KAWANO, M
    HIRANO, T
    MATSUDA, T
    TAGA, T
    HORII, Y
    IWATO, K
    ASAOKU, H
    TANG, B
    TANABE, O
    TANAKA, H
    KURAMOTO, A
    KISHIMOTO, T
    [J]. NATURE, 1988, 332 (6159) : 83 - 85
  • [16] KURZROCK R, 1993, CANCER RES, V53, P2118
  • [17] LANZOTTI VJ, 1997, CANCER, V39, P303
  • [18] MCCANN SM, 1995, HUMAN CYTOKINES THEI, P293
  • [19] MEIR EV, 1990, CANCER RES, V50, P6683
  • [20] AIDS KAPOSI SARCOMA-DERIVED CELLS PRODUCE AND RESPOND TO INTERLEUKIN-6
    MILES, SA
    REZAI, AR
    SALAZARGONZALEZ, JF
    VANDERMEYDEN, M
    STEVENS, RH
    LOGAN, DM
    MITSUYASU, RT
    TAGA, T
    HIRANO, T
    KISHIMOTO, T
    MARTINEZMAZA, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) : 4068 - 4072